- Category: Products
Products
CMS assigns Glaukos’ Epioxa a permanent J-code
Corneal CXL therapy was approved in October 2025 as the first topical drug not requiring removal of the corneal epithelium for keratoconus treatment.Products
Iantrek introduces AlloSpan Canal to its bio-interventional platform
Tech combines nitinol-guided canaloplasty with allogeneic biological scaffolding to restore and maintain Schlemm’s canal—without leaving synthetic hardware in the eye.Products
ForSight Robotics performs FIH robot-based cataract surgery
FIH procedure marks the start of clinical trial testing of the JASPER Platform to secure clinical validation and regulatory submissions.Products
Johnson & Johnson launches expanded parameters for ACUVUE VITA contact lenses
Monthly lens now offers ‘around the clock’ coverage across the full power range (-9.00 to +6.00) for astigmatic patients.Products
Amneal launches generic bimatoprost 0.01% to US market
Generic version of Allergan’s LUMIGAN is indicated for reducing elevated IOP in glaucoma and ocular hypertensive patients.Products
FDA approves extended Vabysmo label for macular edema following RVO
Updated labeling enables IVT treatment beyond 6 months, intended to enable more flexible and tailored treatment plans.Products
Alcon launches Clareon TruPlus monofocal and toric IOL
Latest next-gen IOL features the new Opti-Blance Technology design to increase DOF without sacrificing distance vision qualityProducts
FDA clears Bausch + Lomb's Bi-Blade+ vitrectomy cutter and fluidics technology
Dual-port vitrectomy cutter increases cutting speed from 15K to 25K per minute, while Adaptive Fluidics update expands capabilities of the Stellaris Elite systemProducts
FDA clears the OCULUS Pentacam Cornea OCT
Diagnostic device combines OCT and Schleimpflug imaging to provide advanced cornea visualization via a single, 1-second measurement process.Products
FDA issues nationwide voluntary recall for over 3M eye drop bottles
Federal agency identifies eight types of generic eye drops sold under store-brand names connected to potential risk for sterility issues.Products
FDA approves expanded EYLEA HD dosing intervals
VEGF inhibitor cleared for every 20 weeks among wet AMD and DME patients; clearance based on 96-week data from the PHOTON and PULSAR pivotal trials.Products
Tenpoint's YUVEZZI launches to the US commercial market
First and only dual-agent presbyopia-correcting eye drop offers up to 10 hours of miosis with once-daily dosing.Products
Eyedaptic launches latest version of AI-based smart glasses for AMD
Designed for patients with retinal diseases, the EYE7 is an integrated wearable solution with real-time vision enhancements and a new visual assistant.Products
VirtuaLens launches monovision simulation for VR IOL simulator
Immersive virtual reality IOL patient education system allows patients to “try on” lens options in a virtual setting ahead of cataract surgery.Products
Glaukos' Epioxa now commercially available in the US
Corneal CXL therapy was approved as the first topical drug therapy not requiring removal of the corneal epithelium for keratoconus treatment.Products
Heru debuts PretestPro for its wearable VR-based testing platform
New addition enables full-stack pretesting in under 2 minutes via the company’s signature artificial intelligence and virtual reality-based wearable technology.Products
FDA approves J&J's TECNIS PureSee IOL for cataract patients
Approval is the first extended-depth-of-focus lens with no warning on loss of contrast sensitivity; availability to follow later this year.Products
Hilco Vision launches Ndemex Revitalizing Eye Serum
Latest Bruder product, part of a daily eyelid and lash care routine, is formulated with encapsulated tea tree oil and uses a patented NLP nanotechnology.Products
FDA tentatively approves Gland Pharma's brimonidine tartrate 0.025% generic
Final approval and U.S. market launch are still pending for the generic version of Bausch + Lomb’s over-the-counter LUMIFY redness reliever drops.Products